Telia Ventures

Telia Ventures is the corporate venture arm of Telia Company, the Nordic and Baltic telecommunications group. As a strategic CVC, its mandate is shaped by Telia’s commercial interests rather than pure financial returns, which produces a particular profile in healthcare: investments tend to align with connectivity, edge computing, secure communications, and infrastructure-dependent care delivery.

The healthcare thesis covers digital health and tech-enabled care delivery services, with explicit interest in 5G-enabled health technologies, remote monitoring, and secure telemedicine platforms. That narrows the relevant founder profile to companies whose value proposition genuinely depends on connectivity, network, or infrastructure capabilities that Telia can either provide or deeply understand. For founders whose health product is essentially application software, the strategic fit will be weaker. Specific portfolio companies are not enumerated in the source material, and founders should ask for examples that map to their specific connectivity dependencies.

The firm invests at Series A and Series B, with checks of one to five million dollars. The geographic focus is the Nordic and Baltic region, where Telia operates as a primary infrastructure provider. For founders building remote monitoring, telemedicine, or connected care products that require credible carrier relationships in those markets, Telia Ventures offers commercial access that is genuinely hard to replicate, in addition to capital. Founders should weigh that strategic value against the standard considerations of taking corporate venture money: information rights, exit alignment, and cap table optics.

The team is built around investment professionals embedded in the broader Telia organization, with access to operating and engineering expertise across the carrier. Specific partner names are not provided in the source material, and founders should clarify reporting structure, decision rights, and how strategic introductions actually flow in practice.

The right founders for Telia Ventures are growth-stage health tech teams whose commercial path runs through carrier infrastructure, network capabilities, or secure communications in the Nordic-Baltic region. The wrong founders are companies whose product is incidental to connectivity, where the strategic asymmetry favors the corporate rather than the company. Founders should arrive with a clear articulation of how Telia’s infrastructure and customer relationships compress their commercial timeline, and with thoughtful answers on governance, future financing flexibility, and how to manage potential conflicts with other carriers as the business expands. CVC capital is most useful when the strategic logic is concrete, and Telia Ventures rewards that kind of specificity.